At Daré Bioscience, women’s health is our mission. From clinical trials and non-hormonal contraception to therapies for menopause and vaginal dryness to vaginal health, our research is evidence-based and built exclusively for women.
Dare Bioscience, Inc. has raised $16.7M in total funding.
Dare Bioscience, Inc. is headquartered in San Diego, CA.
At Daré Bioscience, women’s health is our mission. From clinical trials and non-hormonal contraception to therapies for menopause and vaginal dryness to vaginal health, our research is evidence-based and built exclusively for women.
Women's health, especially areas like vaginal health and sexual wellness, has been underfunded and under-researched, and women struggle to tell credible science-backed solutions apart from marketing hype and 'junk science.'
Daré Bioscience is a biotech conducting end-to-end clinical development of targeted therapeutics for women, including products like DARE to PLAY sildenafil cream and DARE to RESTORE vaginal microbiome probiotic capsules.
The company points to a track record of one FDA-approved product, five completed clinical trials submitted to the FDA, over $200 million spent on women's health R&D, and 20+ peer-reviewed publications as evidence its claims are backed by rigorous science rather than marketing.
Publicly traded women's health company (Nasdaq: DARE) led by CEO Sabrina Martucci Johnson.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.